KLOW vs GLOW: What's the Difference Between the Two Blends?

Start with the label. Both vials are built on the same foundation: GHK-Cu, BPC-157 and TB-500, in identical amounts. KLOW simply adds a fourth research peptide, KPV. That's the whole difference, and it's a meaningful one.

3

research peptides in GLOW

4

research peptides in KLOW

1

difference between them: KPV

These three peptides share a vial for a reason. Each one has a research history in tissue repair, and each works through a different mechanism. Think of them as three specialists on one team.

GHK-Cu, the copper peptide. GHK was discovered in 1973, when researchers found a factor in human blood that made old liver tissue produce proteins like young tissue.⁸ The body makes it naturally, but levels decline with age.¹ In lab and animal research, GHK-Cu boosted collagen and elastin production and supported the skin cells that build them, with repair effects reported in skin, lung, bone, liver and stomach-lining models.⁵ One review even reports that GHK can switch at least 4,000 human genes up or down.¹

BPC-157, the gut-derived peptide. BPC-157 is a 15-amino-acid piece of a protein first isolated from human gastric juice.² In rat tendon studies, it sped up tendon cell outgrowth, helped cells survive oxidative stress and increased cell migration in a dose-dependent way.² A 2019 review found the rodent results consistently positive across tendon, ligament and muscle models, while noting the effect is not yet confirmed in humans.⁹

TB-500, the migration specialist. TB-500 is a synthetic copy of LKKTETQ, a short active region of the natural protein thymosin beta-4.⁶ That region is the protein's actin-binding site, and in lab tests it matched the full protein's effect on blood-vessel cell migration.³ Full thymosin beta-4 also boosted skin regrowth over wounds in rats by as much as 61% at day 7.¹⁰

4,000+

human genes GHK can switch up or down¹

15

amino acids in BPC-157²

Up to 61%

more skin regrowth over wounds at day 7, full thymosin beta-4 in rats¹⁰

KPV is tiny: just three amino acids (lysine, proline, valine). It's the tail end of alpha-MSH, a natural hormone best known for its anti-inflammatory effects.⁷ Small as it is, it has a busy research file.

• It shuts down inflammatory switches. In human gut and immune cells, KPV blocked two major inflammation pathways (NF-kB and MAP kinase) and cut inflammatory signals, at nanomolar concentrations.⁴
• It has its own way into cells. KPV enters through PepT1, a transporter that becomes more active in inflamed gut tissue.⁴
• It worked in two mouse colitis models. Treated mice recovered sooner, bounced back to their normal body weight faster and showed fewer inflammatory cells in the colon.⁷
• It doesn't need the usual receptor. KPV still worked in mice without a working MC1R receptor, and every treated animal in that group survived the colitis challenge.⁷

Researchers are even building targeted delivery systems for it: nanoparticles that carry KPV straight to colon cells.¹¹ That's a sign of how seriously the field takes this three-amino-acid peptide.

Because the blends differ by exactly one component, the choice comes down to one question: does your research question involve inflammatory signalling?

• Choose GLOW when your work centres on the repair-and-structure trio: collagen and matrix signalling (GHK-Cu), cell migration (TB-500) and tendon or tissue models (BPC-157).
• Choose KLOW when you also want the inflammation arm. KPV adds NF-kB and cytokine signalling to the same core.⁴
• Running both? Since the core three are identical, the pair makes a natural comparison: the only variable is KPV.

Every lot is tested by an independent lab before it goes on sale. The certificate lists the lot number, the exact measured HPLC purity and the lab that ran it. Match the lot number on your vial to its report in our COA library. New to certificates? Our guide to reading a peptide COA walks through every field.